Medicine safety monitoring applies to all aspects of drug development, but how much is it impacted by patient diversity and study type in clinical trials?

A recent article aims to quantify the under-reporting of adverse events (AEs) in published medical literature, compared with unpublished sources.

New collaborations are seeking better safety knowledge for pregnant and breastfeeding women.